Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study.
Clin Infect Dis
; 78(6): 1698-1706, 2024 Jun 14.
Article
in En
| MEDLINE
| ID: mdl-38525535
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rifampin
/
Tuberculosis, Multidrug-Resistant
/
Ethionamide
/
Linezolid
/
Antitubercular Agents
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Africa
Language:
En
Journal:
Clin Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2024
Document type:
Article
Affiliation country:
Australia
Country of publication:
Estados Unidos